Castle Biosciences CSTL Other Non-Current Assets
Other Non-Current Assets at other companies
Other financials
Where this comes from
Reported directly by Castle Biosciences in its filing.
Tagged under the XBRL concept us-gaap:NotesAndLoansReceivableNetNoncurrent.
The official record: Castle Biosciences’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Castle Biosciences's other non-current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Castle Biosciences's other non-current assets?
- Castle Biosciences (CSTL) reported other non-current assets of $20M in Q4 2025.
- How has Castle Biosciences's other non-current assets changed year-over-year?
- Castle Biosciences's other non-current assets increased by 1528.7% year-over-year, from $1.23M to $20M.
- What is the long-term trend for Castle Biosciences's other non-current assets?
- Over 5 years (2020 to 2025), Castle Biosciences's other non-current assets has grown at a 67.1% compound annual growth rate (CAGR), from $1.54M to $20M.
- What does other non-current assets mean?
- Long-term assets not classified in specific categories — a catch-all for miscellaneous non-current assets.